Literature DB >> 28845622

For Debate: Does Cannabis Use by the Pregnant Mother Affect the Fetus and Newborn?

Paul Merlob1, Bracha Stahl2, Gil Klinger1.   

Abstract

Cannabis, commonly called marijuana, is often used during pregnancy, likely due to the perception that it is a "safe" drug. Changes in legislation in many countries have lead to the increased availability of this drug and to its increasing use during pregnancy, often with other concomitant exposures such as alcohol, tobacco, and other drugs. Herein, we review the medical literature regarding effects of marijuana on the fetus and newborn. Possible effects of in utero exposure to marijuana focus on fetal growth, increase in the rates of stillbirth and preterm delivery, congenital malformations, and neurodevelopmental effects on the child. Published studies for all these outcomes are inconsistent. Fetal weight growth may be somewhat decreased, but the magnitude of this decrease is no greater than 100 g. There is insufficient evidence to conclude on any effect on the stillbirth rate. Although there are some reports of a slight increase in the rate of prematurity, most reports do not support this effect. Marijuana does not appear to be a major teratogen; however, a small increased risk for some congenital birth defects may be associated with early pregnancy use. Neurodevelopmental effects have been associated with marijuana use, but it is difficult to control for the effect of confounders. Despite the lack of conclusive evidence, it is important to remember that marijuana has not been shown to be a harmless drug during pregnancy and may affect the long-term neurodevelopment of the newborn infant. Copyright© of YS Medical Media ltd.

Entities:  

Keywords:  Adverse drug effects; Cannabis; Newborn; Outcome; Pregnancy

Mesh:

Year:  2017        PMID: 28845622     DOI: 10.17458/per.vol15.2017.msk.fd.cannabispregnantmother

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  3 in total

Review 1.  [Position paper on medical cannabis and cannabis-based medicines in pain medicine].

Authors:  Frank Petzke; Matthias Karst; Knud Gastmeier; Lukas Radbruch; Eva Steffen; Winfried Häuser
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

2.  Cannabis use and stressful life events during the perinatal period: cross-sectional results from Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2016.

Authors:  Alicia M Allen; Alesia M Jung; Adam C Alexander; Sharon S Allen; Kenneth D Ward; Mustafa al'Absi
Journal:  Addiction       Date:  2020-03-10       Impact factor: 7.256

3.  Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort.

Authors:  Vanina Tchuente; Odile Sheehy; Jin-Ping Zhao; Jessica Gorgui; Yessica-Haydee Gomez; Anick Berard
Journal:  BMJ Open       Date:  2022-08-08       Impact factor: 3.006

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.